Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Living Cell Technologies Ltd.

www.lctglobal.com

Latest From Living Cell Technologies Ltd.

Pipeline Watch: Phase III Progress With Burosumab, Duvelisib And Galcanezumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Pipeline Watch: LentiGlobin, BMS-986205 Phase III Studies Initiated

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pipeline Watch Approvals

Asia On the Move: ShangPharma Names Former Biogen Executive Chief Biologics Officer

Major Chinese contract research organization ShangPharma appoints chief biologics officer, Sinopharm names new board director, and personnel moves take place at Takeda, AbbVie and J&J.

BioPharmaceutical China

New Zealand Living Cell-Otsuka Partnership Implants Pig Cells Into Parkinson’s Patient

New Zealand’s Living Cell Technologies has taken a key clinical step in regenerative and replacement branded cell therapy work focused on Parkinson’s disease and type 1 diabetes that has drawn investment from Japan’s Otsuka.

BioPharmaceutical Australia
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Living Cell Technologies Ltd.
  • Senior Management
  • Paul Tan, MD, CEO
    Richard Justice, CFO
  • Contact Info
  • Living Cell Technologies Ltd.
    Phone: (61) 3 9886 0247
    P.O. Box 3014 Auburn, VIC 3123
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register